Rogue antibodies could be driving severe COVID-19
Evidence is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.
Evidence is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.
Nature Communications – Bavituximab is a genetically engineered IgG1 chimeric antibody that targets phosphatidylserine. Here the authors report the results of a single-arm phase 2…
Nature Communications – CAR T cell immunotherapy for paediatric solid and brain tumours is constrained by the availability of targetable antigens. Here, the authors investigate…
Nature Metabolism – Inhibitor of mitochondrial transcription treatment leads to reduced oxidative phosphorylation capacity but increases fatty acid oxidation in the liver, leading to protection…
Nature – Decades of evidence shows that exercise leads to healthier, longer lives. Researchers are just starting to work out what it does to cells…
Nature – Browser plug-in alerts users when studies — or their references — have been posted on a site known for raising integrity concerns.
Nature – Disturbances in the gut microbiota of male mice manifest as fitness defects in their offspring by affecting plancenta function, revealing a paternal gut–germline…
Nature Reviews Rheumatology – The peptide hormone adropin, which is downregulated in dermal fibroblasts in patients with systemic sclerosis (SSc), inhibits TGFβ-mediated fibrosis in in…
Nature Reviews Rheumatology – In this Review, Knight and Erkan consider how the 2023 ACR–EULAR classification criteria for antiphospholipid syndrome (APS) can guide future research…
Nature Reviews Chemistry – To achieve net-zero carbon emissions, we must close the carbon cycle for industries that are difficult to electrify. Developing the needed…
Nature Communications – Invasive populations often have low genetic diversity because they originated from a small number of founding individuals. This study shows that in…